The iCMLf is a charitable foundation established by a group of hematologists with a strong interest in Chronic Myeloid Leukemia (CML). The mission of the iCMLf is to improve the outcomes for patients with CML globally. It aims to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML. Scientific advisors and national representatives spanning over 30 countries provide guidance and advice to further the aims of the iCMLf. Read more here.
Following the sudden death of Professor John Goldman the iCMLf Directors have
nominated Professor Tim Hughes as the next chairman of the foundation. Dr Hughes is one of the co-founders of the Foundation and has helped to shape the iCMLf’s strategy and programs for the past five years as member of the Board of Directors.
The recently launched new module of the iCMLf’s Virtual Education Program presents the results of a global survey on the non-adherence of CML patients – a key problem in CML. The survey conducted by the CML Advocates Network evaluated data from 2,546 CML patients from 79 countries.
The webcast is presented by Giora Sharf, co-founder of the CML Advocates Network and President of the Israeli CML Patient Organization.
In addition to the Rowley Prize that the iCMLf awards annually to individuals that have made a major lifetime contribution to the understanding of the biology of CML, the iCMLf Directors have created a second prize. The recently launched Goldman Prize complements the Rowley Prize as a clinical equivalent by recognising lifetime contributions to the management of patients with CML. The new award has been created in memory of the late iCMLf chair to honour Professor Goldman´s commitment to clinical excellence in treating CML.
In 2014 the iCMLf Rowley Prize for persons who have made major contributions to understanding the biology of CML is awarded to Dr Owen Witte, a Distinguished Professor of Microbiology, Immunology and Molecular genetics. Dr Witte is Director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California Los Angeles (UCLA) and a Howard Hughes Medical Institute Investigator. He currently holds the UCLA Presidential Chair in Developmental Immunology.
It is with great sorrow that the iCMLf has learned of the death of Professor John Goldman, after a short illness.
With a worldwide reputation in the study of the biology and treatment of CML, John was a true leader, teacher and inspiration to so many.
The iCMLf Diagnosis and Testing Program launched in 2011 offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in developing countries where it is not currently available.
Building on the success of the current program and the nine projects awarded iCMLf grants, the Foundation will offer further grants in 2014. These iCMLf grants are for projects that will increase local access to CML diagnostics.
Grants are available to physicians, scientists and hematology laboratory staff working in a hospital or research institution. Building local capacity and resource sustainability are important criteria for this iCMLf funding.
Download the PDF file here - topics covered:
We are delighted that over 100 physicians from 21 countries attended this year´s iCMLf Forum for Physicians from Emerging Economic Regions. This annual event is held during the American Society of Hematology meeting.